Sarasin & Partners LLP Pfizer Inc Transaction History

Sarasin & Partners LLP

$10.2 Billion
Q1 2024

A detailed history of Sarasin & Partners LLP transactions in Pfizer Inc stock. As of the latest transaction made, Sarasin & Partners LLP holds 1,405,135 shares of PFE stock, worth $39.3 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

1,405,135

Previous 1,382,631 1.63%

Holding current value

$39.3 Million

Previous $39.8 Million 2.04%

% of portfolio

0.38%

Previous 0.44%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	BUY	$25.89 - $29.73 $582,628 - $669,043	22,504 Added 1.63%	1,405,135 $39 Million
Q4 2023 Jan 09, 2024	BUY	$26.13 - $33.94 $25.3 Million - $32.9 Million	969,973 Added 235.05%	1,382,631 $39.8 Million
Q3 2023 Oct 05, 2023	SELL	$32.09 - $37.51 $5.01 Million - $5.86 Million	-156,199 Reduced 27.46%	412,658 $13.7 Million
Q2 2023 Jul 10, 2023	BUY	$36.12 - $41.79 $3.81 Million - $4.4 Million	105,357 Added 22.73%	568,857 $20.9 Million
Q1 2023 May 05, 2023	BUY	$39.39 - $51.28 $260,052 - $338,550	6,602 Added 1.44%	463,500 $18.9 Million

Q1 2023 Apr 27, 2023	BUY	$39.39 - $51.28 $825,535 - $1.07 Million	20,958 Added 4.81%	456,898 $18.6 Million
Q4 2022 Jan 30, 2023	BUY	$41.75 - $54.5 $376,251 - $491,154	9,012 Added 2.11%	435,940 $22.3 Million
Q3 2022 Oct 18, 2022	BUY	$43.76 - $53.42 $403,948 - $493,120	9,231 Added 2.21%	426,928 $18.7 Million
Q2 2022 Jul 13, 2022	BUY	$46.53 - $55.17 $634,436 - $752,242	13,635 Added 3.37%	417,697 $21.9 Million
Q1 2022 Apr 11, 2022	SELL	$45.75 - $56.69 $2.41 Million - $2.98 Million	-52,639 Reduced 11.53%	404,062 $20.9 Million
Q4 2021 Jan 19, 2022	SELL	$41.32 - $61.25 $6.15 Million - $9.12 Million	-148,828 Reduced 24.58%	456,701 $27 Million
Q3 2021 Oct 22, 2021	SELL	$39.25 - $50.42 $3,611 - $4,638	-92 Reduced 0.02%	605,529 $26 Million
Q2 2021 Jul 13, 2021	SELL	$35.91 - $40.68 $55,624 - $63,013	-1,549 Reduced 0.26%	605,621 $23.7 Million
Q1 2021 Apr 29, 2021	SELL	$33.49 - $37.77 $13.4 Million - $15.1 Million	-399,599 Reduced 39.69%	607,170 $22 Million
Q4 2020 Jan 19, 2021	SELL	$33.47 - $42.56 $20.6 Million - $26.2 Million	-614,686 Reduced 37.91%	1,006,769 $37.1 Million
Q3 2020 Nov 09, 2020	SELL	$31.75 - $37.25 $4.82 Million - $5.66 Million	-151,923 Reduced 8.57%	1,621,455 $59.5 Million
Q2 2020 Jul 17, 2020	SELL	$30.12 - $36.54 $69.2 Million - $83.9 Million	-2,297,223 Reduced 56.43%	1,773,378 $58 Million
Q1 2020 Apr 30, 2020	SELL	$27.03 - $38.62 $4.77 Million - $6.82 Million	-176,534 Reduced 4.16%	4,070,601 $133 Million
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $4.73 Million - $5.37 Million	-143,634 Reduced 3.27%	4,247,135 $166 Million
Q3 2019 Nov 08, 2019	BUY	$32.49 - $42.13 $5.86 Million - $7.6 Million	180,473 Added 4.29%	4,390,769 $158 Million
Q2 2019 Jul 18, 2019	BUY	$36.98 - $41.52 $1.51 Million - $1.69 Million	40,813 Added 0.98%	4,210,296 $182 Million
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $1.17 Million - $1.28 Million	31,075 Added 0.75%	4,169,483 $177 Million
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $932,512 - $1.06 Million	-24,240 Reduced 0.58%	4,138,408 $181 Million
Q3 2018 Nov 09, 2018	SELL	$34.47 - $41.81 $15.6 Million - $18.9 Million	-452,989 Reduced 9.81%	4,162,648 $183 Million
Q2 2018 Aug 07, 2018	BUY	$32.98 - $35.16 $2.3 Million - $2.45 Million	69,794 Added 1.54%	4,615,637 $167 Million
Q1 2018 May 01, 2018	SELL	$31.91 - $37.02 $14.5 Million - $16.8 Million	-453,331 Reduced 9.07%	4,545,843 $161 Million
Q4 2017 Feb 06, 2018	BUY	$33.26 - $35.29 $1.86 Million - $1.97 Million	55,921 Added 1.13%	4,999,174 $181 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $153 Million - $169 Million	4,943,253	4,943,253 $176 Million

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sarasin & Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Sarasin & Partners LLP with notifications on news.

Account

Sarasin & Partners LLP Pfizer Inc Transaction History